Comparison of safety, efficacy and serum immune indexes of Clostridium butyricum Enterococcus triple viable vs Bifidobacterium triple viable in the treatment of bronchial asthma in children.

MLA

Zhang, Chun, and Qing-Bai Wu. “Comparison of Safety, Efficacy and Serum Immune Indexes of Clostridium Butyricum Enterococcus Triple Viable vs Bifidobacterium Triple Viable in the Treatment of Bronchial Asthma in Children.” Pakistan Journal of Pharmaceutical Sciences, vol. 35, no. 5, Sept. 2022, pp. 1407–14. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=36451571&authtype=sso&custid=ns315887.

APA

Zhang, C., & Wu, Q.-B. (2022). Comparison of safety, efficacy and serum immune indexes of Clostridium butyricum Enterococcus triple viable vs Bifidobacterium triple viable in the treatment of bronchial asthma in children. Pakistan Journal of Pharmaceutical Sciences, 35(5), 1407–1414.

Chicago

Zhang, Chun, and Qing-Bai Wu. 2022. “Comparison of Safety, Efficacy and Serum Immune Indexes of Clostridium Butyricum Enterococcus Triple Viable vs Bifidobacterium Triple Viable in the Treatment of Bronchial Asthma in Children.” Pakistan Journal of Pharmaceutical Sciences 35 (5): 1407–14. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=36451571&authtype=sso&custid=ns315887.